CACaption Management, LLC
Institutional investor · Portfolio as of Q2 2022
Top Holdings1,395 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
PALO ALTO NETWORKS INC | 310,800 | $153.5M | 2.1% | — | — | — | Increased — |
SPDR S&P BIOTECH ETF | 1.6M | $118.4M | 1.6% | — | — | — | Increased — |
DEVON ENERGY CORP | 1.8M | $99.8M | 1.4% | — | — | — | Decreased — |
TRIP.COM GROUP LTD-ADR | 3M | $81.3M | 1.1% | — | — | — | Increased — |
ALNYLAM PHARMACEUTICALS INC | 529,000 | $77.2M | 1.1% | — | — | — | Increased — |
TRIP.COM GROUP LTD-ADR | 2.8M | $77.1M | 1.1% | — | — | — | Increased — |
NCR VOYIX CORP | 2.4M | $75.3M | 1.0% | — | — | — | Increased — |
PROCTER & GAMBLE CO/THE | 515,700 | $74.2M | 1.0% | — | — | — | New — |
ENERGY SELECT SECTOR SPDR | 857,000 | $61.4M | 0.8% | — | — | — | Increased — |
DIAMONDBACK ENERGY INC | 489,700 | $59.3M | 0.8% | $100.04 | +1.23% | 4 qtrssince 2021-Q3 | Increased 45 |
DIAMONDBACK ENERGY INC | 488,700 | $59.2M | 0.8% | — | — | — | Increased — |
ALNYLAM PHARMACEUTICALS INC | 387,500 | $56.5M | 0.8% | — | — | — | Increased — |
TRIP.COM GROUP LTD-ADR | 2.1M | $56.4M | 0.8% | $25.73 | +7.95% | 4 qtrssince 2021-Q3 | Increased 52 |
VISTRA CORP | 2.3M | $53.7M | 0.7% | — | — | — | Increased — |
PETROLEO BRASILEIRO-SPON ADR | 4.5M | $52.6M | 0.7% | $5.28 | +0.02% | 4 qtrssince 2021-Q3 | Increased 67 |
UNION PACIFIC CORP | 235,500 | $50.2M | 0.7% | — | — | — | Increased — |
PETROLEO BRASILEIRO-SPON ADR | 4.3M | $50.2M | 0.7% | — | — | — | Decreased — |
DEVON ENERGY CORP | 904,100 | $49.8M | 0.7% | — | — | — | Increased — |
ACTIVISION BLIZZARD INC | 630,000 | $49.1M | 0.7% | — | — | — | Increased — |
SPDR S&P BIOTECH ETF | 595,100 | $44.4M | 0.6% | — | — | — | Increased — |
Caption Management, LLC manages $7.3B across 1395 positions as of Q2 2022. Top holdings: PANW (2.1%), XBI (1.6%), DVN (1.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 229 new positions, 246 exits, 103 increased. Top move: PBR (INCREASED, conviction 67). Portfolio: $7.3B across 1395 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer